|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.14 USD | -2.61% |
|
+2.71% | -13.51% |
| Dec. 11 | Citigroup Adjusts DexCom Price Target to $77 From $75, Maintains Buy Rating | MT |
| Dec. 05 | Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds | RE |
| Capitalization | 26.89B 22.91B 21.4B 20.13B 37.06B 2,435B 40.49B 250B 96.87B 1,148B 101B 98.76B 4,188B | P/E ratio 2025 * |
33.4x | P/E ratio 2026 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise value | 27.04B 23.04B 21.52B 20.25B 37.27B 2,449B 40.72B 251B 97.42B 1,154B 101B 99.32B 4,212B | EV / Sales 2025 * |
5.82x | EV / Sales 2026 * | 5.03x |
| Free-Float |
95.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: DexCom, Inc.
| 1 day | -2.38% | ||
| 1 week | +2.70% | ||
| Current month | +5.97% | ||
| 1 month | +12.83% | ||
| 3 months | -11.76% | ||
| 6 months | -18.82% | ||
| Current year | -13.51% |
| 1 week | 64 |  | 69.77 |
| 1 month | 57.2 | | 69.77 |
| Current year | 54.11 | | 93.25 |
| 1 year | 54.11 | | 93.25 |
| 3 years | 54.11 | | 142 |
| 5 years | 54.11 | | 164.86 |
| 10 years | 10.66 | | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 46 | 2025-09-13 |
Jereme Sylvain
DFI | Director of Finance/CFO | 45 | 2021-03-18 |
| Chief Tech/Sci/R&D Officer | 48 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 66 | 2009-11-19 |
Steven Altman
BRD | Director/Board Member | 63 | 2013-11-06 |
Mark Foletta
CHM | Chairman | 65 | 2025-09-13 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.46% | 26 M€ | +12.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.46% | +2.70% | -14.79% | -42.40% | 26.89B | |
| +0.93% | -0.72% | +9.06% | +13.42% | 214B | |
| -0.61% | -2.19% | +19.84% | +24.38% | 128B | |
| +0.08% | +1.80% | +48.96% | +106.79% | 66.83B | |
| -0.24% | +3.19% | -11.90% | -21.22% | 57.21B | |
| +1.79% | +0.23% | +17.62% | +71.97% | 51.16B | |
| -0.71% | -4.97% | +15.61% | +28.45% | 24.78B | |
| -1.06% | -3.80% | +5.39% | -35.53% | 23.72B | |
| +0.63% | -4.56% | -23.93% | +16.41% | 21.83B | |
| +0.69% | -2.89% | +8.82% | -1.71% | 20.69B | |
| Average | -0.09% | -1.27% | +7.47% | +16.05% | 63.54B | |
| Weighted average by Cap. | +0.21% | -1.02% | +12.20% | +23.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.64B 3.96B 3.7B 3.48B 6.4B 421B 6.99B 43.14B 16.74B 198B 17.43B 17.06B 724B | 5.23B 4.46B 4.16B 3.92B 7.21B 474B 7.88B 48.61B 18.85B 223B 19.64B 19.22B 815B |
| Net income | 831M 708M 661M 622M 1.15B 75.29B 1.25B 7.72B 2.99B 35.49B 3.12B 3.05B 129B | 989M 843M 787M 741M 1.36B 89.61B 1.49B 9.19B 3.56B 42.24B 3.71B 3.63B 154B |
| Net Debt | 153M 130M 121M 114M 210M 13.81B 230M 1.42B 549M 6.51B 572M 560M 23.76B | -587M -500M -467M -439M -809M -53.16B -884M -5.45B -2.11B -25.06B -2.2B -2.16B -91.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 67.22 $ | -2.49% | 4,293,494 |
| 25-12-11 | 68.94 $ | +2.04% | 6,926,610 |
| 25-12-10 | 67.56 $ | +1.85% | 8,527,643 |
| 25-12-09 | 66.33 $ | +1.08% | 5,136,011 |
| 25-12-08 | 65.62 $ | +0.20% | 4,681,315 |
Delayed Quote Nasdaq, December 12, 2025 at 01:44 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
